Literature DB >> 10373119

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

J Holash1, P C Maisonpierre, D Compton, P Boland, C R Alexander, D Zagzag, G D Yancopoulos, S J Wiegand.   

Abstract

In contrast with the prevailing view that most tumors and metastases begin as avascular masses, evidence is presented here that a subset of tumors instead initially grows by coopting existing host vessels. This coopted host vasculature does not immediately undergo angiogenesis to support the tumor but instead regresses, leading to a secondarily avascular tumor and massive tumor cell loss. Ultimately, however, the remaining tumor is rescued by robust angiogenesis at the tumor margin. The expression patterns of the angiogenic antagonist angiopoietin-2 and of pro-angiogenic vascular endothelial growth factor (VEGF) suggest that these proteins may be critical regulators of this balance between vascular regression and growth.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10373119     DOI: 10.1126/science.284.5422.1994

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  575 in total

Review 1.  Anticancer drug targets: approaching angiogenesis.

Authors:  E Keshet; S A Ben-Sasson
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 2.  Angiogenesis.

Authors:  C D Kontos; B H Annex
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.113

3.  Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer.

Authors:  C J Kuo; F Farnebo; E Y Yu; R Christofferson; R A Swearingen; R Carter; H A von Recum; J Yuan; J Kamihara; E Flynn; R D'Amato; J Folkman; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 4.  Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name?

Authors:  M J Bissell
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

5.  Circulating endothelial precursors: mystery, reality, and promise.

Authors:  S Rafii
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

Review 6.  Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation.

Authors:  P Vajkoczy; A Ullrich; M D Menger
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

Review 7.  Role of hematopoietic stem cells in angiogenesis.

Authors:  T Suda; N Takakura
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

Review 8.  Vascular growth factors in cerebral ischemia.

Authors:  S D Croll; S J Wiegand
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

9.  Getting Tie(2)d up in angiogenesis.

Authors:  Markus Ramsauer; Patricia A D'Amore
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 10.  β1 integrin: Critical path to antiangiogenic therapy resistance and beyond.

Authors:  Arman Jahangiri; Manish K Aghi; W Shawn Carbonell
Journal:  Cancer Res       Date:  2013-12-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.